US Patent Application No: 2008/0213,786

Number of patents in Portfolio can not be more than 2000

Treatment of rheumatoid arthritis with galectin-3 antagonists

Stats

ATTORNEY / AGENT: (SPONSORED)
 

Importance

Loading Importance Indicators... loading....

Abstract

The invention encompasses a novel method of treating an inflammatory disease, such as rheumatoid arthritis, and novel methods of identifying and screening for drugs useful in the treatment of inflammatory diseases, such as rheumatoid arthritis, and their clinical symptoms. The inventors have made the discovery that the activity of galectin-3, a .beta.-galactoside-binding lectin known to have an effect on some cancers, has a significant impact on the pathophysiology of rheumatoid arthritis. The symptoms of an inflammatory disease, such as rheumatoid arthritis, may be alleviated by administering a compound that inhibits the activity of galectin-3.

Loading the Abstract Image... loading....

First Claim

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
ENTELOS, INC.FOSTER CITY, CA12

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hurez, Vincent Jacques Albany, CA 7 20
Michelson, Seth G San Jose, CA 10 28
Struemper, Herbert Bethlehem, PA 4 5
Wennerberg, Leif Gustaf Mountain View, CA 11 24

Patent Citation Ranking

Forward Cites

Patent Info (Count) # Cites Year
 
E. I. DU PONT DE NEMOURS AND COMPANY (1)
8,129,091 Method for preparing a composite printing form using a template 0 2009